tiprankstipranks
Trending News
More News >
Genix Pharmaceuticals Corporation (TSE:GENX)
:GENX
Canadian Market

Genix Pharmaceuticals (GENX) Income Statement

Compare
1 Followers

Genix Pharmaceuticals Income Statement

Last quarter (Q3 2024), Genix Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Genix Pharmaceuticals's net income was $-82.17K. See Genix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Oct 23Oct 22Oct 21Oct 20Oct 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 3.26K$ ―$ ―$ ―$ -45.69K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 547.42K$ 564.17K$ 536.61K$ 361.57K$ 253.00
EBITDA
$ -3.80M$ -497.69K$ -1.11M$ -353.21K$ -162.67K
Operating Income
$ -880.89K$ -1.03M$ -1.65M$ -715.21K$ -143.34K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -4.40M$ -1.07M$ -1.65M$ -718.66K$ -164.70K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Genix Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis